{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:02:15Z","timestamp":1790949735696,"version":"4.1.0"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.00420","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:38:41Z","timestamp":1596587921000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":144,"title":["Secondary Bacterial Infections in Patients With Viral Pneumonia"],"prefix":"10.3389","volume":"7","author":[{"given":"Prasanth","family":"Manohar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Nachimuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Welburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Leptihn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1053\/j.semdp.2019.04.006","article-title":"Emerging respiratory Infections: The infectious disease pathology of SARS, MERS, pandemic influenza, and Legionella","volume":"36","author":"Bradley","year":"2019","journal-title":"Semin Diagn Pathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fmicb.2017.01041","article-title":"Secondary bacterial infections associated with influenza pandemics","volume":"8","author":"Morris","year":"2017","journal-title":"Front Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.3389\/fimmu.2018.02345","article-title":"Resolving viral-induced secondary bacterial infection in COPD: a concise review","volume":"9","author":"Wang","year":"2018","journal-title":"Front Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1164\/rccm.201205-0806OC","article-title":"Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease","volume":"186","author":"Mallia","year":"2012","journal-title":"Am J Respir Crit Care Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jama.2012.194139","article-title":"Bacterial coinfection in influenza: a grand rounds review","volume":"309","author":"Chertow","year":"2013","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.ajpath.2014.08.030","article-title":"Infectious disease theme issue the role of viral, host, and secondary bacterial factors in influenza pathogenesis","volume":"185","author":"Kash","year":"2015","journal-title":"Am J Pathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/s12879-018-3548-0","article-title":"The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a (H1N1) pdm09","volume":"18","author":"MacIntyre","year":"2018","journal-title":"BMC Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.chom.2011.05.006","article-title":"Viral infection augments Nod1\/2 signaling to potentiate lethality associated with secondary bacterial infections","volume":"9","author":"Kim","year":"2011","journal-title":"Cell Host Microbe."},{"key":"B9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.chom.2010.01.010","article-title":"Article influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection","volume":"7","author":"Jamieson","year":"2010","journal-title":"Cell Host Microbe."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.2147\/TCRM.S87789","article-title":"Virus-induced secondary bacterial infection: a concise review","volume":"11","author":"Hendaus","year":"2015","journal-title":"Ther Clin Risk Manag."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0005901","DOI":"10.1371\/journal.pntd.0005901","article-title":"Secondary bacterial infections and antibiotic resistance among tungiasis patients in Western, Kenya","volume":"11","author":"Nyangacha","year":"2017","journal-title":"PLoS Neglect Trop D."},{"key":"B12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1165\/rcmb.2007-0417OC","article-title":"Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae","volume":"42","author":"Pittet","year":"2010","journal-title":"Am J Resp Cell Mol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11908-007-0030-3","article-title":"Bacterial biofilm in upper respiratory tract infections","volume":"9","author":"Morris","year":"2007","journal-title":"Curr Infect Dis Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.epidem.2009.09.001","article-title":"Intervention strategies for an influenza pandemic taking into account secondary bacterial infections","volume":"1","author":"Handel","year":"2009","journal-title":"Epidem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3851\/IMP1730","article-title":"Preventing and treating secondary bacterial infections with antiviral agents","volume":"16","author":"McCullers","year":"2011","journal-title":"Antivir Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1099\/0022-1317-51-10-808","article-title":"Secondary bacterial infections complicating skin lesions","volume":"51","author":"Brook","year":"2002","journal-title":"J Med Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1128\/JCM.33.8.2139-2140.1995","article-title":"Microbiology of secondary bacterial infection in scabies lesions","volume":"33","author":"Brook","year":"1995","journal-title":"J Clin Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/BCR.0000000000000062","article-title":"Secondary bacterial infection and empirical antibiotic use in toxic epidermal necrolysis patients","volume":"35","author":"Mahar","year":"2014","journal-title":"J Burn Care Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/82_2014_394","article-title":"Secondary bacterial infections in influenza virus infection pathogenesis in influenza pathogenesis and control","volume":"385","author":"Smith","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"B20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-3-319-48683-3_7","article-title":"Bacterial resistance against antibiotics","volume-title":"Drug Resistance in Bacteria, Fungi, Malaria, and Cancer","author":"Kumar","year":"2017"},{"key":"B21","unstructured":""},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IM9.0000000000000018","article-title":"A call for a multidisciplinary future of phage therapy to combat multi-drug resistant bacterial infections","volume":"2","author":"Loh","year":"2020","journal-title":"Infect Microb Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2000524","DOI":"10.1183\/13993003.00524-2020","article-title":"Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study","volume":"55","author":"Du","year":"2020","journal-title":"Eur Respir J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"619","DOI":"10.21037\/atm-20-3300","article-title":"Efficacy and safety of antibiotic agents in children with COVID-19: a rapid review","volume":"8","author":"Wang","year":"2020","journal-title":"Ann Transl Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"P475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA."},{"key":"B29","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N Engl J Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00134-020-06028-z","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"3","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"ciaa199","DOI":"10.1093\/cid\/ciaa199","article-title":"Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study","volume":"29","author":"Wu","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"B36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/irv.12739","article-title":"68 Consecutive patients assessed for COVID-19 infection; experience from a UK regional infectious disease unit","volume":"14","author":"Easom","year":"2020","journal-title":"Influenza Other Respir Viruses"},{"key":"B37","doi-asserted-by":"publisher","first-page":"m1295","DOI":"10.1136\/bmj.m1295","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ."},{"key":"B38","first-page":"ciaa272","article-title":"Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China","volume-title":"Clin Infect Dis.","author":"Wang","year":"2020"},{"key":"B39","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ijid.2020.03.070","article-title":"Epidemiological and clinical features of 125 hospitalized patients with COVID-19 in Fuyang, Anhui, China","volume":"95","author":"Wang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/00003246-199905000-00020","article-title":"Nosocomial infections in medical intensive care units in the United States","volume":"27","author":"Richards","year":"1999","journal-title":"Crit Care Med."},{"key":"B41","unstructured":""},{"key":"B42","unstructured":""},{"key":"B43","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.2353\/ajpath.2007.061088","article-title":"Pathology and pathogenesis of severe acute respiratory syndrome","volume":"170","author":"Gu","year":"2007","journal-title":"Am J Pathol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.antiviral.2013.08.016","article-title":"Clinical management and infection control of SARS: lessons learned","volume":"100","author":"Cheng","year":"2013","journal-title":"Antiviral Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1043\/1543-2165(2004)128<195:AODDTS>2.0.CO;2","article-title":"Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis","volume":"128","author":"Chong","year":"2004","journal-title":"Arch Pathol Lab Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/S0140-6736(03)13265-5","article-title":"Development of a standard treatment protocol for severe acute respiratory syndrome","volume":"361","author":"So","year":"2003","journal-title":"Lancet."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJMoa030685","article-title":"A major outbreak of severe acute respiratory syndrome in Hong Kong","volume":"348","author":"Lee","year":"2003","journal-title":"N Engl J Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1056\/NEJMoa030666","article-title":"A cluster of cases of severe acute respiratory syndrome in Hong Kong","volume":"348","author":"Tsang","year":"2003","journal-title":"N Engl J Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","article-title":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet."},{"key":"B50","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1099\/jmm.0.05320-0","article-title":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China","volume":"52","author":"Zhao","year":"2003","journal-title":"J Med Microbiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3201\/eid1005.030640","article-title":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients","volume":"10","author":"Wang","year":"2004","journal-title":"Emerg Infect Dis."},{"key":"B52","unstructured":""},{"key":"B53","doi-asserted-by":"publisher","first-page":"650","DOI":"10.4161\/viru.32077","article-title":"Middle east respiratory syndrome (MERS) A new zoonotic viral pneumonia","volume":"5","author":"Cunha","year":"2014","journal-title":"Virulence."},{"key":"B54","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijid.2014.03.1372","article-title":"Community case clusters of middle east respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study","volume":"23","author":"Memish","year":"2014","journal-title":"Int J Infect Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"389","DOI":"10.7326\/M13-2486","article-title":"Clinical course and outcomes of critically ill patients with middle east respiratory syndrome coronavirus infection","volume":"160","author":"Arabi","year":"2014","journal-title":"Ann Intern Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ijid.2013.12.003","article-title":"Ribavirin and interferon therapy in patients infected with the middle east respiratory syndrome coronavirus: an observational study","volume":"20","author":"Al-Tawfiq","year":"2014","journal-title":"Int J Infect Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijid.2014.09.003","article-title":"Clinical aspects and outcomes of 70 patients with middle east respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia","volume":"29","author":"Saad","year":"2014","journal-title":"Int J Infect Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","article-title":"Epidemiological, demographic, and clinical characteristics of 47 cases of middle east respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","volume":"13","author":"Assiri","year":"2013","journal-title":"Lancet Infect Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa1303729","article-title":"Family cluster of middle east respiratory syndrome coronavirus infections","volume":"368","author":"Memish","year":"2013","journal-title":"N Engl J Med."},{"key":"B60","unstructured":""},{"key":"B61","unstructured":""},{"key":"B62","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1086\/421525","article-title":"Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza","volume":"190","author":"McCullers","year":"2004","journal-title":"J Infect Dis."},{"key":"B63","unstructured":"2012"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1086\/368163","article-title":"Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae","volume":"187","author":"McCullers","year":"2003","journal-title":"J Infect Dis."},{"key":"B65","first-page":"201","article-title":"Epidemiologic and clinical features among patients hospitalized in Wisconsin with 2009. H1N1 influenza A virus infections, April to August. 2009","volume":"109","author":"Chitnis","year":"2010","journal-title":"Wisconsin Med J"},{"key":"B66","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1750-2659.2012.00405.x","article-title":"Clinical features of the hospitalized patients with 2009 pandemic influenza A (H1N1) in Santa Fe, Argentina","volume":"7","author":"Kusznierz","year":"2013","journal-title":"Influenza Other Respir Viruses."},{"key":"B67","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s13054-015-1120-5","article-title":"Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship","volume":"19","author":"Crotty","year":"2015","journal-title":"Critical Care."},{"key":"B68","doi-asserted-by":"publisher","first-page":"ofaa066","DOI":"10.1093\/ofid\/ofaa066","article-title":"Influenza and bacterial coinfection in adults with community-acquired pneumonia admitted to conventional wards: risk factors, clinical features, and outcomes","volume":"7","author":"Abelenda-Alonso","year":"2020","journal-title":"Open Forum Infect Dis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1086\/652446","article-title":"Fatalities associated with the 2009. H1N1 influenza A virus in New York city","volume":"50","author":"Hughes","year":"2010","journal-title":"Clin Infect Dis."},{"key":"B70","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2353\/ajpath.2010.100115","article-title":"2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States","volume":"177","author":"Shieh","year":"2010","journal-title":"Am J Pathol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/modpathol.2011.180","article-title":"Histopathological and immunohistochemical findings of 20 autopsy cases with (2009). H1N1 virus infection","volume":"25","author":"Nakajima","year":"2012","journal-title":"Modern Pathol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1056\/NEJMoa0904252","article-title":"Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico","volume":"361","author":"Perez-Padilla","year":"2009","journal-title":"N Engl J Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"eaau5480","DOI":"10.1126\/science.aau5480","article-title":"Antimicrobial peptides: application informed by evolution","volume":"368","author":"Lazzaro","year":"2020","journal-title":"Science"},{"key":"B74","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrmicro1098","article-title":"Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?","volume":"3","author":"Brogden","year":"2005","journal-title":"Nat Rev Microbiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4161\/viru.1.1.10229","article-title":"One step at a time: action mechanism of Sushi 1 antimicrobial peptide and derived molecules","volume":"1","author":"Leptihn","year":"2010","journal-title":"Virulence."},{"key":"B76","doi-asserted-by":"publisher","first-page":"9161","DOI":"10.1021\/bi1011578","article-title":"Correlation of charge, hydrophobicity, and structure with antimicrobial activity of S1 and MIRIAM peptides","volume":"49","author":"Leptihn","year":"2010","journal-title":"Biochemistry."},{"key":"B77","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage therapy: a renewed approach to combat antibiotic-resistant bacteria","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell Host Microbe."},{"key":"B78","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3389\/fmicb.2019.00574","article-title":"Therapeutic characterization and efficacy of bacteriophage cocktails infecting Escherichia coli, klebsiella pneumoniae and enterobacter species","volume":"10","author":"Manohar","year":"2019","journal-title":"Front Microbiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e00066","DOI":"10.1128\/CMR.00066-18","article-title":"Phage therapy in the postantibiotic era","volume":"32","author":"Altamirano","year":"2019","journal-title":"Clin Microbiol Rev."},{"key":"B80","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3389\/fmicb.2017.00981","article-title":"Phage therapy: past, present and future","volume":"8","author":"Abedon","year":"2017","journal-title":"Front Microbiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00284-016-1166-x","article-title":"Phage therapy in bacterial infections treatment: one hundred years after the discovery of bacteriophages","volume":"74","author":"Cisek","year":"2017","journal-title":"Curr Microbiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/IM9.0000000000000013","article-title":"Pharmacological and immunological aspects of phage therapy","volume":"1","author":"Manohar","year":"2019","journal-title":"Infect Microb Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3389\/fmicb.2020.01434","article-title":"Secondary bacterial infections during pulmonary viral disease: phage therapeutics as alternatives to antibiotics?","volume":"11","author":"Manohar","year":"2020","journal-title":"Front Microbiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.tips.2017.01.004","article-title":"Small molecules that sabotage bacterial virulence","volume":"38","author":"Johnson","year":"2017","journal-title":"Trends Pharmacol Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e1004321","DOI":"10.1371\/journal.ppat.1004321","article-title":"Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity","volume":"10","author":"Starkey","year":"2014","journal-title":"PLoS Pathog."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00420\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:38:47Z","timestamp":1596587927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00420\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":85,"alternative-id":["10.3389\/fmed.2020.00420"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.00420","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,5]]},"article-number":"420"}}